344 related articles for article (PubMed ID: 12508715)
1. Alterations of non-enzymatic biochemistry in uremia, diabetes, and atherosclerosis ("carbonyl stress").
Miyata T
Bull Mem Acad R Med Belg; 2002; 157(3-4):189-96; discussion 196-8. PubMed ID: 12508715
[TBL] [Abstract][Full Text] [Related]
2. Advanced glycation in uraemic toxicity.
van Ypersele de Strihou C
EDTNA ERCA J; 2003; 29(3):148-50. PubMed ID: 14552090
[TBL] [Abstract][Full Text] [Related]
3. Reactive carbonyl compounds related uremic toxicity ("carbonyl stress").
Miyata T; Sugiyama S; Saito A; Kurokawa K
Kidney Int Suppl; 2001 Feb; 78():S25-31. PubMed ID: 11168978
[TBL] [Abstract][Full Text] [Related]
4. Relevance of oxidative and carbonyl stress to long-term uremic complications.
Miyata T; Kurokawa K; van Ypersele de Strihou C
Kidney Int Suppl; 2000 Aug; 76():S120-5. PubMed ID: 10936808
[TBL] [Abstract][Full Text] [Related]
5. Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications.
Miyata T; van Ypersele de Strihou C; Kurokawa K; Baynes JW
Kidney Int; 1999 Feb; 55(2):389-99. PubMed ID: 9987064
[TBL] [Abstract][Full Text] [Related]
6. Advanced glycation and lipoxidation end products: reactive carbonyl compounds-related uraemic toxicity.
Miyata T; Saito A; Kurokawa K; van Ypersele de Strihou C
Nephrol Dial Transplant; 2001; 16 Suppl 4():8-11. PubMed ID: 11402090
[TBL] [Abstract][Full Text] [Related]
7. [Disease/aging and oxidative/carbonyl stress].
Toshio M; Yasuhiko U; Nangaku M
Nihon Ronen Igakkai Zasshi; 2003 Jul; 40(4):348-51. PubMed ID: 12934565
[No Abstract] [Full Text] [Related]
8. Carbonyl stress: increased carbonyl modification of tissue and cellular proteins in uremia.
Miyata T; Izuhara Y; Sakai H; Kurokawa K
Perit Dial Int; 1999; 19 Suppl 2():S58-61. PubMed ID: 10406495
[TBL] [Abstract][Full Text] [Related]
9. Implication of carbonyl stress in long-term uraemic complications.
Wada T; Miyata T; Kurokawa K
Nephrol Dial Transplant; 1999; 14 Suppl 1():79-81. PubMed ID: 10048461
[TBL] [Abstract][Full Text] [Related]
10. Glycoxidation and lipoxidation in atherogenesis.
Baynes JW; Thorpe SR
Free Radic Biol Med; 2000 Jun; 28(12):1708-16. PubMed ID: 10946212
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II receptor antagonists and angiotensin-converting enzyme inhibitors lower in vitro the formation of advanced glycation end products: biochemical mechanisms.
Miyata T; van Ypersele de Strihou C; Ueda Y; Ichimori K; Inagi R; Onogi H; Ishikawa N; Nangaku M; Kurokawa K
J Am Soc Nephrol; 2002 Oct; 13(10):2478-87. PubMed ID: 12239236
[TBL] [Abstract][Full Text] [Related]
12. Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: is there oxidative stress in uremia?
Miyata T; Fu MX; Kurokawa K; van Ypersele de Strihou C; Thorpe SR; Baynes JW
Kidney Int; 1998 Oct; 54(4):1290-5. PubMed ID: 9767546
[TBL] [Abstract][Full Text] [Related]
13. Pathways of the Maillard reaction under physiological conditions.
Henning C; Glomb MA
Glycoconj J; 2016 Aug; 33(4):499-512. PubMed ID: 27291759
[TBL] [Abstract][Full Text] [Related]
14. Oxidative protein damage with carbohydrates and lipids in uremia: 'Carbonyl stress'.
Inagi R; Miyata T
Blood Purif; 1999; 17(2-3):95-8. PubMed ID: 10449866
[TBL] [Abstract][Full Text] [Related]
15. The Role of Glyoxalase in Glycation and Carbonyl Stress Induced Metabolic Disorders.
Saeed M; Kausar MA; Singh R; Siddiqui AJ; Akhter A
Curr Protein Pept Sci; 2020; 21(9):846-859. PubMed ID: 32368974
[TBL] [Abstract][Full Text] [Related]
16. Oxidation conspires with glycation to generate noxious advanced glycation end products in renal failure.
Miyata T; Maeda K; Kurokawa K; van Ypersele de Strihou C
Nephrol Dial Transplant; 1997 Feb; 12(2):255-8. PubMed ID: 9132640
[TBL] [Abstract][Full Text] [Related]
17. Glyoxalase I deficiency is associated with an unusual level of advanced glycation end products in a hemodialysis patient.
Miyata T; van Ypersele de Strihou C; Imasawa T; Yoshino A; Ueda Y; Ogura H; Kominami K; Onogi H; Inagi R; Nangaku M; Kurokawa K
Kidney Int; 2001 Dec; 60(6):2351-9. PubMed ID: 11737610
[TBL] [Abstract][Full Text] [Related]
18. Advanced glycation end products in clinical nephrology.
Kalousová M; Zima T; Tesar V; Stípek S; Sulková S
Kidney Blood Press Res; 2004; 27(1):18-28. PubMed ID: 14679311
[TBL] [Abstract][Full Text] [Related]
19. AGEs and carbonyl stress: potential pathogenetic factors of long-term uraemic complications.
Zoccali C; Mallamaci F; Tripepi G
Nephrol Dial Transplant; 2000; 15 Suppl 2():7-11. PubMed ID: 11051031
[TBL] [Abstract][Full Text] [Related]
20. Lipoxidation products as biomarkers of oxidative damage to proteins during lipid peroxidation reactions.
Requena JR; Fu MX; Ahmed MU; Jenkins AJ; Lyons TJ; Thorpe SR
Nephrol Dial Transplant; 1996; 11 Suppl 5():48-53. PubMed ID: 9044307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]